Fox Run Management, L.L.C. Invitae Corp Transaction History

Fox Run Management, L.L.C.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$6.28 - $15.59 $92,177 - $228,830	-14,678 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$14.7 - $28.67 $26,004 - $50,717	1,769 Added 13.7%	14,678 $224,000
Q3 2021 Nov 15, 2021	BUY	$24.31 - $33.6 $313,817 - $433,742	12,909 New	12,909 $367,000
Q2 2020 Jul 31, 2020	SELL	$11.71 - $30.29 $131,210 - $339,399	-11,205 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$7.64 - $27.5 $85,606 - $308,137	11,205 New	11,205 $153,000

Q4 2017 Jan 18, 2018	SELL	$7.86 - $9.99 $261,738 - $332,667	-33,300 Closed	0 $0
Q3 2017 Oct 23, 2017	BUY	$8.89 - $10.4 $296,037 - $346,320	33,300	33,300 $312,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.